How does Rosuvastatin impact lipid metabolism in patients with non-alcoholic fatty liver disease, and what role does it play in reducing liver-associated cardiovascular risks?
Sahil KapoorExplorer
How does Rosuvastatin impact lipid metabolism in patients with non-alcoholic fatty liver disease?
Share
Rosuvastatin improves lipid metabolism by reducing LDL cholesterol and triglycerides while increasing HDL cholesterol, potentially decreasing cardiovascular risks in NAFLD patients.